At the recent conference for pharmaceutical and biotech manufacturers, Interphex 2012, Pharmaceutical Manufacturing magazine Editor in Chief Agnes Shanley discussed trends in the industry’s use of process analytical technology (PAT) and quality by design (QbD) with Emerson’s Director of Life Sciences Industry Consulting, Chris Amstutz. Their discussion was captured in this 4:48 YouTube video, Emerson […]
It was just about a year ago that the U.S. Food and Drug Administration published their Guidance for Industry – Process Validation: General Principles and Practices. I caught up with Emerson’s Heather Schwalje, a senior consultant on the Life Sciences industry team. Heather shared key elements from this FDA process validation guidance document and how […]
An Emerson fellow blogger, Alan Babbitt, and his Emerson Global Life Sciences Blog was first to the scene to cover a great Bioprocess International article, Hurry Up and Wait? The article, by Emerson senior Life Sciences industry consultant, Michalle Adkins, describes the problems manual processes have on product cycle times for highly regulated process manufacturers. […]
I caught up the other day with Emerson’s Shenling Yang, who is a senior project execution engineer in the Life Sciences and Food & Beverage (LSFB) industry group. You may recall Shenling from earlier posts. She shared two pieces of news with me. The first is that the Critical Data Backup application developed by the […]
I’d like to welcome a new voice, Emerson’s Alan Babbitt, to the blogosphere. Alan and team’s purpose with this new blog, The Emerson Global Life Sciences Blog, is: …to provide insight into the Life Sciences Industry from a number of perspectives. We will provide periodic updates on industry trends that include commentary on the state […]
Powered by WordPress